Orbis Biosciences Inc
- View government funding actions
- Kansas City, KS 661032159
- Phone: 816-223-2662
- Corporate URL: www.orbisbio.com
- Estimated Number of Employees: 5
- Estimated Annual Receipts: $2,177,230
- Business Start Date: 2007
- Contact Person: Maria Flynn
- Contact Phone: 816-223-2662
- Contact Email: maria@orbisbio.com
- Business Structure:
- Corporate Entity (Not Tax Exempt)
- Business Type:
- Self Certified Small Disadvantaged Business
- For Profit Organization
- Industries Served: Medicinal and Botanical Manufacturing, Pharmaceutical Preparation Manufacturing
- Product Areas: DRUGS AND BIOLOGICALS, R&D-PROD/SERV IMPROVEMENT-A RES/EXP, R&D- ECONOMIC GROWTH: PRODUCT/SERVICE IMPROVEMENT (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT), R&D- ECONOMIC GROWTH: MANUFACTURING TECHNOLOGY (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT), R&D-MANUFACTURING TECH-A RES/EXPL D, R&D- ECONOMIC GROWTH: MANUFACTURING TECHNOLOGY (ADVANCED DEVELOPMENT), MANUFACTURING TECHNOLOGY (ADVANCED), R&D- ECONOMIC GROWTH: MANUFACTURING TECHNOLOGY (ENGINEERING DEVELOPMENT), R&D-MANUFACTURING TECH-ENG DEV, R&D- GENERAL SCIENCE/TECHNOLOGY: ENGINEERING (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT), ENGINEERING (APPLIED/EXPLORATORY), ENGINEERING (ADVANCED), R&D- GENERAL SCIENCE/TECHNOLOGY: ENGINEERING (ADVANCED DEVELOPMENT), R&D- GENERAL SCIENCE/TECHNOLOGY: LIFE SCIENCES (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT), LIFE SCIENCES (APPLIED/EXPLORATORY), LIFE SCIENCES (ENGINEERING), R&D- GENERAL SCIENCE/TECHNOLOGY: LIFE SCIENCES (ENGINEERING DEVELOPMENT), INSTALL OF MATERIALS HANDLING EQ, INSTALLATION OF EQUIPMENT- MATERIALS HANDLING EQUIPMENT
Sampling of Federal Government Funding Actions/Set Asides
In order by amount of set aside monies.
- $99,962 - Tuesday the 31st of January 2012
Department Of Army
W6QK ACC-APG NATICK
SBIR PHASE I "NEXT GENERATION OF CONTROLLED-RELEASE BACTERIOCINS/ANTI-MICROBIALS"
© Copyright 2019
The Collier Report published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources.
No reliance should be made by readers or Collier Report subscribers.
Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances.
Requests for the modification of displayed information may be made to help.desk@1918.media.